A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)

Clinical trial NCT02554812 · TERMINATED

Trial details

NCT number: NCT02554812
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2015-11-09
Primary completion: 2023-03-23
Enrollment: 409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.